Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

DCM Shriram Fine Chemicals Ltd (DSFCL) Share Price & Fundamentals

Company Overview

Founded Year

2021

Listed Year

2023

Headquarter

India

MD/CEO

-

Website

-

Company Facts

What we do

DCM Shriram Fine Chemicals Ltd manufactures and sells fine chemicals and pharmaceutical intermediates, specializing in chemical processes like photochlorination and cyanation.

Founded in

2,021

Market share

One of the world's leading producers of anti-infective pharmaceutical intermediates.

Problem solved

Provides high-quality, technologically advanced fine chemicals and intermediates supporting pharmaceutical and chemical industries.

Top clients or who we serve

Serves pharmaceutical companies focusing on anti-infective drugs; operates in B2B space.

Key management

-

Our journey and innovations

Began fine chemical business in the 1970s, evolved through acquisitions and demerger to specialize in high-value intermediates with European technology affiliations.

Where we operate

Primarily India, with global export clientele in pharmaceuticals.

Top products or what we offer

Pharmaceutical intermediates, specialty chemicals, contract manufacturing services.

Top brands

-

Raw materials needed

Toluene and other chemical feedstocks for photochlorination and cyanation reactions.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue primarily from recurring contract manufacturing and sales of chemical intermediates.

Our industry position

Strong position in pharmaceutical intermediates market, especially anti-infective segment globally.

Financial highlights

-

Geographical revenue split

-

Order book

-

Whats driving growth

Rising global demand for anti-infective drug intermediates and chemical manufacturing outsourcing.

Our future plans

Expand manufacturing capacity and product portfolio post demerger to scale in fine chemicals sector.

Our green promise

-

Our people and values

-

Key challenges ahead

Managing raw material cost volatility and sustaining technology leadership.

Interesting facts

Among world leaders in photochlorination-based chemical intermediates production.

Risks and strategy

-

Market Footprint

Top Clients

Top Clients

Serves pharmaceutical companies focusing on anti-infective drugs; operates in B2B space.

Top Products

Top Products

Pharmaceutical intermediates, specialty chemicals, contract manufacturing services.

Price Movement & Share Holding

Today's High/Low

24.826.06

52 Week High/Low

17.2852.5
Past Returns

1 week

-3.24%

1 month

-11.01%

3 month

-11.01%

1 year

-11.01%

3 year

-11.01%

5 year

-11.01%

Share Holding

Promoters

50.11%

FII

0.97%

DII

11.19%

Retail

30.04%

Others

7.69%

Company Overview

Founded Year

2021

Listed Year

2023

Headquarter

India

MD/CEO

-

Website

-

Price Movement & Share Holding

Today's High/Low

24.826.06

52 Week High/Low

17.2852.5

Past Returns

1 week

-3.24%

1 month

-11.01%

3 month

-11.01%

1 year

-11.01%

3 year

-11.01%

5 year

-11.01%

Share Holding

Promoters

50.11%

FII

0.97%

DII

11.19%

Retail

30.04%

Others

7.69%

Company Facts

What we do

DCM Shriram Fine Chemicals Ltd manufactures and sells fine chemicals and pharmaceutical intermediates, specializing in chemical processes like photochlorination and cyanation.

Founded in

2021

Market share

One of the world's leading producers of anti-infective pharmaceutical intermediates.

Problem solved

Provides high-quality, technologically advanced fine chemicals and intermediates supporting pharmaceutical and chemical industries.

Top clients or who we serve

Serves pharmaceutical companies focusing on anti-infective drugs; operates in B2B space.

Our journey and innovations

Began fine chemical business in the 1970s, evolved through acquisitions and demerger to specialize in high-value intermediates with European technology affiliations.

Where we operate

Primarily India, with global export clientele in pharmaceuticals.

Top products or what we offer

Pharmaceutical intermediates, specialty chemicals, contract manufacturing services.

Raw materials needed

Toluene and other chemical feedstocks for photochlorination and cyanation reactions.

Recurring vs cyclical contribution

Revenue primarily from recurring contract manufacturing and sales of chemical intermediates.

Our industry position

Strong position in pharmaceutical intermediates market, especially anti-infective segment globally.

Whats driving growth

Rising global demand for anti-infective drug intermediates and chemical manufacturing outsourcing.

Our future plans

Expand manufacturing capacity and product portfolio post demerger to scale in fine chemicals sector.

Key challenges ahead

Managing raw material cost volatility and sustaining technology leadership.

Interesting facts

Among world leaders in photochlorination-based chemical intermediates production.

Market Footprint

Top Clients

Top Clients

Serves pharmaceutical companies focusing on anti-infective drugs; operates in B2B space.

Top Products

Top Products

Pharmaceutical intermediates, specialty chemicals, contract manufacturing services.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions